Earnings History Data for Ikena Oncology (IKNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ikena Oncology

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2022 PM IKNA Ikena Oncology 94.00 -0.48 -0.50 0.00 Ikena Oncology GAAP EPS of -$0.48 beats by $0.01, revenue of $6.4M beats by $2.08M
[11/7/2022 8:28 AM]
2.29 0.02 
(0.88%)
2.32 0.05 
(2.20%)
2.25 - 17.50 123,395 70,000 551
17-03-2022 PM IKNA Ikena Oncology, Inc. 201.44 0.07 -0.52 0.00 Ikena Oncology GAAP EPS of $0.08 beats by $0.59, revenue of $20.21M beats by $15.42M
[3/17/2022 9:14 AM]
7.77 1.46 
(23.14%)
6.36 0.05 
(0.79%)
5.31 - 37.61 101,316 133,270 4,265
10-11-2021 PM IKNA Ikena Oncology 541.00 -0.40 -0.41 0.00 Ikena Oncology EPS beats by $0.02, misses on revenue
[11/10/2021 9:08 AM]
16.57 1.49 
(9.88%)
0.0 0.0 
(0.00%)
9.63 - 37.61 114,768 120,000 0